Cupps Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cupps Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-50,076	Closed	-$3.68M	–	179
2016 Q2	$3.68M	Buy	50,076 +44,876	+863%	+$3.17M	0.95%	30
2016 Q1	$332K	Buy	5,200 +559	+12%	+$35.3K	0.06%	155
2015 Q4	$319K	Buy	+4,641	New	+$307K	0.04%	133
2014 Q2	–	Sell	-48,880	Closed	-$2.54M	–	213
2014 Q1	$2.54M	Sell	48,880 -37,808	-44%	-$2.01M	0.19%	120
2013 Q4	$4.61M	Buy	86,688 +82,993	+2,246%	+$4.23M	0.31%	95
2013 Q3	$171K	Buy	+3,695	New	+$162K	0.01%	144

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cupps Capital Management's BMY Position: Q3 2016 in Review

Cupps Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 50,076 shares — an estimated $3.68M sold.

Cupps Capital Management first reported a position in BMY in Q3 2013 and held it in 6 quarters. The position peaked at $4.61M in Q4 2013. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Cupps Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
Cupps Capital Management sold 50,076 Bristol-Myers Squibb shares in Q3 2016, an estimated $3.68M.
Cupps Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 6 quarters.
Cupps Capital Management's Bristol-Myers Squibb position peaked at $4.61M in Q4 2013.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.